verve therapeutics eli lilly

News

Eli Lilly Buys Verve Therapeutics

Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion

Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.Under the agreement, the pharmaceutical company will buy all of the gene-editing startup’s shares outstanding for $10.

· 13h · on MSN

Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

· 19h

Eli Lilly strikes deal to buy Crispr gene-editing biotech Verve

16hon MSN

This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

Verve Therapeutics’ stock was rallying by a record 80% on Eli Lilly’s premium purchase price for the drug-development company ...

13h

Eli Lilly Buys Verve Therapeutics: Aims To Permanently Lower Your Cholesterol

Eli Lilly (LLY) will acquire Verve Therapeutics (VERV) for up to $13.5/share, aiming to revolutionize cholesterol treatment.

17hon MSN

Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, accelerating a push into experimental cardiovascular therapies.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results